Insiders own 24% of INmune Bio, Inc. (NASDAQ:INMB) shares but retail investors control 53% of the company

Key Insights INmune Bio's significant retail investors ownership suggests that the key decisions are influenced by...

Related Keywords

Inmune Bio ,Public Company Ownership ,Xencor Inc ,Inmune Bio Inc ,Chief Executive ,Nc ,Shareholders ,Company ,